Success Story: Health Economics Researcher Earns I-140 NIW Approval for Work Addressing Cardiometabolic and Alzheimer’s Disease Burdens
Client’s Testimonial:
"I am posting this in good faith and in appreciation of WG’s support throughout this process. No conflicts of interest have influenced either my writing or my opinions shared during this process.”
On April 15th, 2026, we received another EB-2 NIW (National Interest Waiver) approval for a Manager in the Field of Health Economics (Approval Notice).
General Field: Health Economics
Position at the Time of Case Filing: Manager – Evidence Generation
Country of Origin: China
State of Residence at the Time of Filing: New Jersey
Approval Notice Date: April 15th, 2026
Processing Time: 10 months, 19 days (Premium Processing Upgrade Requested)
Case Summary:
We are pleased to share that our client’s I-140 NIW petition was approved. The client holds a Ph.D. in economics, focusing on health economics, and is currently employed as an evidence generation manager, where he continues to conduct real-world evidence research in health economics in the pharmaceutical industry.
The client’s proposed endeavor focused on elucidating the burden of disease and treatment efficacy for cardiometabolic and Alzheimer’s diseases through real-world evidence studies. The petition framed this work as nationally important because it supports improved health outcomes for the older U.S. population and helps address major public health concerns, including obesity, diabetes, cardiovascular risk, and Alzheimer’s disease.
To demonstrate that the client was well-positioned to advance this work, the petition highlighted 8 peer-reviewed journal articles, 12 conference abstracts, and 400 citations. These numbers were not presented as automatically sufficient. Instead, the petition explained that the client’s work had been relied upon by other researchers studying global disease burden, diabetes treatment, obesity trends, and public health interventions, showing independent use of the client’s findings in ongoing public and pharmaceutical research.
The petition also emphasized peer trust in the client’s expertise. The client had completed at least 20 peer reviews for authoritative journals and research networks, demonstrating that the research community trusted him to evaluate work in health economics, disease burden analysis, and health outcomes research.
By connecting the client’s advanced training, current employment, publication record, citation impact, review service, and real-world evidence expertise to pressing U.S. healthcare challenges, the petition showed why his continued work would benefit the United States. We congratulate our client on this I-140 NIW approval and wish him continued success in advancing health economics research and evidence-based healthcare strategies in the United States.